NASDAQ: CRAC
Crown Reserve Acquisition Corp I Stock

$9.90-0.24 (-2.37%)
Updated Dec 9, 2025
CRAC Price
$9.90
Fair Value Price
N/A
Market Cap
$213.47M
52 Week Low
$9.89
52 Week High
$10.14
P/E
N/A
P/B
8,488.16x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
20.08
Operating Cash Flow
N/A
Beta
0.05
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CRAC Overview

A blank‑check SPAC (Special Purpose Acquisition Company), incorporated in the Cayman Islands on April 29, 2025, aiming to complete a merger or acquisition in healthcare-related sectors such as pharmaceuticals, med-tech, medical equipment, or healthcare IT

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CRAC's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Shell Company

Industry Rating
F
CRAC
Ranked
Unranked of 29

Top Ranked Stocks in Industry

View Top Shell Company Stocks

Be the first to know about important CRAC news, forecast changes, insider trades & much more!

CRAC News

Overview

Due Diligence Score

Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CRAC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CRAC is good value based on its book value relative to its share price (8,488.16x), compared to the US Shell Companies industry average (-52.68x)
P/B vs Industry Valuation
CRAC's debt to equity ratio (20.08) is considered high
Healthy Debt to Equity Financials
Insufficient data to perform Discounted... subscribe to Premium to read more.
Below Fair Value Valuation
There are 30 more CRAC due diligence checks available for Premium users.

Valuation

CRAC price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
8,488.16x
Industry
-52.68x
CRAC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CRAC's financial health

Profit margin

Revenue
$0.0
Net Income
$96.0
Profit Margin
0%

Assets to liabilities

Assets
$530.1k
Liabilities
$505.0k
Debt to equity
20.08
CRAC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$96.0
Investing
$0.0
Financing
$0.0

CRAC vs Shell Company Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CRAC$213.47M-2.32%N/A8,488.16x
GSHR$210.88M+0.19%N/A-56.30x
EGHA$207.87M+0.10%84.50x-41.75x
HAVAU$207.55M0.00%N/A-1,326.78x
IPOD$206.58M+0.29%102.10x-38.62x

Crown Reserve Acquisition I Stock FAQ

What is Crown Reserve Acquisition I's quote symbol?

(NASDAQ: CRAC) Crown Reserve Acquisition I trades on the NASDAQ under the ticker symbol CRAC. Crown Reserve Acquisition I stock quotes can also be displayed as NASDAQ: CRAC.

If you're new to stock investing, here's how to buy Crown Reserve Acquisition I stock.

What is the 52 week high and low for Crown Reserve Acquisition I (NASDAQ: CRAC)?

(NASDAQ: CRAC) Crown Reserve Acquisition I's 52-week high was $10.14, and its 52-week low was $9.89. It is currently -2.37% from its 52-week high and 0.1% from its 52-week low.

How much is Crown Reserve Acquisition I's stock price per share?

(NASDAQ: CRAC) Crown Reserve Acquisition I stock price per share is $9.90 today (as of Dec 9, 2025).

What is Crown Reserve Acquisition I's Market Cap?

(NASDAQ: CRAC) Crown Reserve Acquisition I's market cap is $213.47M, as of Dec 11, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Crown Reserve Acquisition I's market cap is calculated by multiplying CRAC's current stock price of $9.90 by CRAC's total outstanding shares of 21,562,500.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.